The Impact of motivational interviewing on illness perception in patients with stable coronary artery disease. A

Sara Mülhauser1, Martine Bonhôte Börner1, Hugo Saner1

  • 11 Universitätsklinik für Kardiologie, Inselspital, Universitätsspital Bern.

Pflege
|February 1, 2018
PubMed

Insights

Motivational interviewing (MI) can improve illness perception in patients with coronary heart disease (CHD). A short MI intervention positively affected emotional reactions to the disease in CHD patients post-PTCA.

Area of Science:

  • Cardiology
  • Psychology
  • Health Behavior

Background:

  • Coronary heart disease (CHD) is a leading cause of death in individuals over 60.
  • Lifestyle factors significantly influence CHD risk.
  • Effective cardiac rehabilitation requires patients to understand their condition, which is often lacking.

Purpose of the Study:

  • To evaluate the impact of motivational interviewing (MI) on illness perception in patients with stable CHD.
  • To assess if a brief MI intervention enhances understanding of CHD and its risk factors.

Main Methods:

  • A randomized-controlled trial involving 312 patients with stable CHD after percutaneous transluminal coronary angioplasty (PTCA).
  • The intervention group received a short MI session; the control group received usual care.
  • Illness perception was measured using the Illness Perception Questionnaire-Revised before and six months after the intervention.

Main Results:

  • A significant improvement was observed in the emotional reactions domain of illness perception after the MI intervention.
  • The study included 312 patients (148 intervention, 164 control) with a mean age of 66.2 years.

Conclusions:

  • A single, short motivational interviewing intervention may be effective in improving illness perception in stable CHD patients.
  • Further research is needed to determine if more intensive MI interventions yield greater benefits.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Secondary Motives: Power Motivation and Achievement Motivation01:27

Secondary Motives: Power Motivation and Achievement Motivation

Power motivation and achievement motivation are two essential social motives identified by psychologist David McClelland. These motives influence behavior in various personal and professional contexts, shaping how individuals interact with others and pursue their goals.
Power motivation is characterized by the desire to influence, control, or have an impact on others. It is shaped by an individual's experiences, social environment, and cultural context. People with high power motivation are...
587